Yüklüyor......
Linking tyrosine kinase inhibitor-mediated inflammation with normal epithelial cell homeostasis and tumor therapeutic responses
Receptor tyrosine kinases (RTKs) bearing oncogenic mutations in EGFR, ALK and ROS1 occur in a significant subset of lung adenocarcinomas. Tyrosine kinase inhibitors (TKIs) targeting tumor cells dependent on these oncogenic RTKs yield tumor shrinkage, but also a variety of adverse events. Skin toxici...
Kaydedildi:
| Yayımlandı: | Cancer Drug Resist |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6333470/ https://ncbi.nlm.nih.gov/pubmed/30656289 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.20517/cdr.2018.12 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|